The causal associations of alcohol consumption and smoking with psoriasis are investigated.
The nature of acne-related misinformation available online is evaluated.
The efficacy of topical antifribrinolytic tranexamic acid (TXA) in preventing postoperative bleeding when included in wound care on granulating defects in the setting of Mohs micrographic surgery is assessed.
The therapeutic response to the quadrivalent or nonavalent human papillomavirus (HPV) vaccine in patients with palmoplantar warts is evaluated.
We speak with prominent alopecia researchers and experts to gain insights into the burden associated with hair loss as well as standard and new treatment options for alopecia.
The efficacy, safety, pharmacokinetics, and immunogenicity of adalimumab combined with MTX compared with that adalimumab in patients with chronic plaque psoriasis is evaluated.
The approval was based on data from the phase 3 POETYK PSO-1 and POETYK PSO-2 trials in adults with moderate to severe plaque psoriasis.
Theoretical annual costs of OTC moisturizer are compared with costs of atopic dermatitis; Medicaid coverage is also reviewed.
Exposure to low-dose methotrexate is associated with an increased risk of melanoma, according to a meta-analysis of 17 studies.
Researchers sought to investigate the reliability and characteristic content of the most viewed alopecia-related videos on TikTok focusing on diagnoses, content type, and content creators.
B-VEC is an investigational topical gene therapy designed to deliver 2 copies of the COL7A1 gene when applied directly to DEB wounds.
Contact allergies in patients with rosacea are assessed.
The Companies are in violation of the FD&C Act, as these products are being marketed with unauthorized claims to remove lesions, including moles and skin tags.
The most significant pre- and post-surgical assessments surgeons and dermatologists should perform in patients undergoing rhinoplasty are provided.
CTP-543 is an investigational oral selective inhibitor of JAK1 and JAK2.
The approval was based on data from the two phase 3 trials that included patients aged 12 years and older with mild to severe plaque psoriasis.
The effects of isotretinoin on hepatic, renal, and hematologic functions are evaluated.
The approval was based on data from two phase 3 studies, which included patients 12 years of age and older with nonsegmental vitiligo who had depigmented areas.
The safety and efficacy of lenabasum use in patients with refractory cutaneous dermatomyositis is assessed.
Researchers sought to investigate the efficacy and safety of photodynamic therapy in treatment of rosacea.